Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease - Concepedia

Concepedia

Publication | Open Access

Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer’s disease

DOI Full Paper Access

29

Citations

19

References

2015

Year

Jian Jeffrey Chen, Qingyian Liu, Chester Yuan, Vijay Gore, Patrícia Luciana da Costa Lopez, Vu Ma, Albert Amegadzie, Wenyuan Qian, Ted Judd, Ana Minatti,

Bioorganic & Medicinal Chemistry Letters

Alzheimer's DiseaseMedicine2-Aminooxazoline 3-AzaxanthenesPharmacological AgentAlzheimer ’Efficacious β-Secretase InhibitorsNeurologyDrug DevelopmentPharmacologyInhibitory ActivityTreatmentDrug Discovery

References

	Year	Citations

Page 1

Page 1